NP / PA
Larsson, Katelyn
Larsson, Katelyn was paid $365K by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoLARSSON, KATELYN
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1174053888assigned 06/14/2017
33bProvider typePhysician Assistant
28Total paid$365K
24GClaims6,294
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Physician Assistant providers in Rhode Island
Rank by total paid#10 of 215
Median peer was paid$17K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,010 | $131K | |
| 2019 | 556 | $28K | |
| 2020 | 953 | $42K | |
| 2021 | 359 | $48K | |
| 2022 | 693 | $55K | |
| 2023 | 505 | $44K | |
| 2024incomplete | 218 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 1,891 | 1,694 | $105K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 19% | 582 | 568 | $71K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13% | 572 | 558 | $48K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.2% | 343 | 322 | $30K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.3% | 39 | 38 | $27K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 249 | 239 | $20K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.9% | 180 | 168 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 546 | 531 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 608 | 575 | $9K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.5% | 482 | 290 | $6K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 64 | 46 | $4K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 24 | 24 | $4K |
18 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 70 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 19 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 18 | $2K |
| 85027 | <1% | 121 | $1K | |
| 82728 | <1% | 52 | $1K | |
| 96127 | <1% | 174 | $998.40 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $959.11 |
| 80061 | Lipid panel | <1% | 13 | $869.10 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 18 | $819.80 |
| 83655 | <1% | 68 | $742.49 | |
| 92551 | <1% | 27 | $511.34 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $431.94 |
| 90686 | <1% | 25 | $305.65 | |
| 87081 | <1% | 29 | $272.53 | |
| 83718 | <1% | 14 | $182.30 | |
| 85018 | <1% | 12 | $154.87 | |
| 82465 | <1% | 14 | $96.83 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16 | $91.44 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.